Important points from the introduction:
SARS-CoV-2 is a zoontic born virus.
There are seven different CoVs which infect humans.
The beta CoVs, namely SARS-CoV, SARS-CoV-2 and MERS-CoV, are zoontic and have caused outbreaks. The other human infecting CoVs, called endemic human CoVs, cause mild cold like sumptoms.
Most CoVs likely have their evolutionary origins in bats.
CoVs posses a large +ssRNA genome, 2/3rds of which is comprised of PP1a and PP1b, which encodes replicase polyproteins (RDRPs) which are cleaved into 16 cleavage products by Mprotease and PLprotease.
The proteins nsp3, nsp4, and nsp6 create a replication organelle (RO) by hijacking an intracellular membrane for both replicating the genome and producing virus mRNAs for structural proteins. These structural proteins include S (spike), E (envelope), M (membrane), and N (nucleocapsid) proteins.
Drug targets for the virus include the S protein, RdRp, RNA helicase, and viral methyl transferases.
SARS-CoV and SARS-CoV-2 share an 80% genetic identity and highly conserved protein structures. Both bind to the ACE2 receptor which is found on the surface of Vero E6 Cells.
For these reasons, research on SARS-CoV can, in some cases, be translated to SARS-CoV-2.